The abstract submission is now open!
Abstract submission deadline
Tuesday, 26 November 2024, 21:00 CET (Central European Time)
Abstract submission categories
- Antibody-based therapies
- Cellular and gene therapies
- DNA damage repair and epigenetics
- Immunotherapy
- Kinase-targeting agents and cell signalling modulators
- Molecular profiling applications
- Artificial intelligence (AI) and digital therapeutics
- Methodological, financial and regulatory aspects
- Miscellaneous
Outcome notifications
Outcome notifications are expected to be made available to first authors by mid-December 2024.
Presentation and publication of accepted abstracts
The ESMO TAT 2025 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.
First and presenting authors must register for the Congress and present onsite.
Detailed instructions for the preparation of slide presentations and posters will be made available on the ESMO website by end-December 2024 (in the “Information for Presenters” section) along with scheduling notices.
Accepted abstracts will be published online only in the ESMO TAT 2025 Abstract Book, a supplement to the official ESMO journal, ESMO Open.
Publication schedule for accepted abstracts
Abstracts accepted for presentation during ESMO TAT 2025 will be released online according to a schedule which will be available on the ESMO website (in the “Press & Media” section) in due course.
ESMO Merit Travel Grants
A limited number of ESMO Merit Travel Grants to ESMO TAT 2025 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO TAT 2025 Scientific Committee on a competitive basis from among the accepted abstracts.